Skip to content
OpenCapital
Get started

NuSkin Enterprises NUS Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

The Beauty Health Company logo
The Beauty Health CompanySKIN
-$2.49M+37.6%
USANA Health Sciences logo
USANA Health SciencesUSNA
——
Celsius Holdings, Inc. logo
Celsius Holdings, Inc.CELH
——

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's increase (decrease) in accounts receivable?
NuSkin Enterprises (NUS) reported increase (decrease) in accounts receivable of $5.74M in Q1 2026.
How has NuSkin Enterprises's increase (decrease) in accounts receivable changed year-over-year?
NuSkin Enterprises's increase (decrease) in accounts receivable decreased by 2.4% year-over-year, from $5.88M to $5.74M.
What is the long-term trend for NuSkin Enterprises's increase (decrease) in accounts receivable?
Over 2 years (2021 to 2025), NuSkin Enterprises's increase (decrease) in accounts receivable has grown at a -29.5% compound annual growth rate (CAGR), from -$20.22M to -$10.06M.